tiprankstipranks
Generation Bio Co. (GBIO)
NASDAQ:GBIO
US Market

Generation Bio (GBIO) Financial Statements

Compare
157 Followers

Generation Bio Financial Overview

Generation Bio's market cap is currently $35.57M. The company's EPS TTM is $-2.191; its P/E ratio is ―; Generation Bio is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 5.90M----
Operating Income$ -138.56M$ -141.18M$ -119.10M$ -81.11M$ -62.30M
EBITDA$ -133.30M$ -136.05M$ -114.57M$ -77.68M$ -60.44M
Net Income$ -126.61M$ -136.64M$ -119.15M$ -80.52M$ -61.32M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 374.76M$ 376.26M$ 476.77M$ 294.15M$ 42.14M
Total Debt$ 97.89M$ 81.71M$ 80.83M$ 0.00$ 0.00
Net Debt$ -166.47M$ -197.38M$ -294.32M$ -262.33M$ -15.08M
Total Liabilities$ 171.63M$ 93.77M$ 95.03M$ 26.14M$ 140.73M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -60.14M$ -111.25M$ -97.67M$ -75.66M$ -60.33M
Operating Cash Flow$ -52.74M$ -102.45M$ -91.82M$ -70.14M$ -40.35M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Generation Bio Earnings and Revenue History

Generation Bio Debt to Assets

Generation Bio Cash Flow

Generation Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis